Name: Understanding Amyotrophic Lateral Sclerosis: Causes and Management: Understanding Causes, Managing Care,And Exploring Treatment Advances Inamyotrophic Lateral Sclerosis (en Inglés)
SKU: 63929157
Price: 883.33 MXN
Availability: InStock
Author: Mona El-Banna
ISBN: 9786208420321

portada Understanding Amyotrophic Lateral Sclerosis: Causes and Management: Understanding Causes, Managing Care,And Exploring Treatment Advances Inamyotrophic Lateral Sclerosis (en Inglés)

Understanding Amyotrophic Lateral Sclerosis: Causes and Management: Understanding Causes, Managing Care,And Exploring Treatment Advances Inamyotrophic Lateral Sclerosis (en Inglés)

Formato

Libro Físico

Editorial

Lap Lambert Academic Publishing

Autor

Mona El-Banna

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

ISBN13

9786208420321

Understanding Amyotrophic Lateral Sclerosis: Causes and Management: Understanding Causes, Managing Care,And Exploring Treatment Advances Inamyotrophic Lateral Sclerosis (en Inglés)

Mona El-Banna (Autor) · Lap Lambert Academic Publishing · Tapa Blanda

Libro Nuevo Importado

Envío: 22 a 27 días háb.

$ 1,766.66$ 883.33

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 10 unidades

$ 883.33

¡Envío Gratis! Llega entre el 02 Oct y el 12 Oct a CUAUHTÉMOC, Ciudad de México. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Understanding Amyotrophic Lateral Sclerosis: Causes and Management: Understanding Causes, Managing Care,And Exploring Treatment Advances Inamyotrophic Lateral Sclerosis (en Inglés)"

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder marked by muscle weakness, atrophy, fasciculations, and spasticity due to motor neuron degeneration. Symptoms progress from focal weakness to difficulties in speaking, swallowing, and breathing, with eventual paralysis. The disease arises from mechanisms such as disrupted RNA metabolism (e.g., TDP-43 and FUS mutations), cytoskeletal and axonal transport defects (e.g., PFN1, TUBA4A mutations), excitotoxicity, and oxidative stress. While incurable, treatments like Riluzole and Edaravone can modestly slow progression, and supportive care-such as non-invasive ventilation, feeding tubes, and physical therapy-helps manage symptoms. Emerging therapies, including gene and RNA-targeted approaches, hold promise for the future.